Home
About
Publications Trends
Recent Publications
Expert Search
Archive
pulmonary embolism (pe)
What Are the Symptoms of PE?
The symptoms of PE can be
nonspecific
and may include:
Sudden shortness of breath
Chest pain that may become worse when breathing in
Rapid heart rate
Coughing, sometimes with bloody sputum
It's crucial to seek immediate medical attention if these symptoms are present, especially in individuals with cancer.
Frequently asked queries:
What is Pulmonary Embolism (PE)?
Why is PE Common in Cancer Patients?
What Are the Symptoms of PE?
How is PE Diagnosed in Cancer Patients?
How is PE Treated in Cancer Patients?
Can PE Be Prevented in Cancer Patients?
What is the Prognosis for Cancer Patients with PE?
How Do Patient Assistance Programs (PAPs) Work?
How is PR Related to Cancer?
What Types of Allogeneic Cells Are Used?
How Do Chromosomal Abnormalities Influence Cancer Treatment?
How Can Patients Benefit from Being Part of an MDT?
How Do Genetic Mutations Influence Cancer Treatment?
Why are Walk-a-thons Important for Cancer Awareness?
Why is Aneuploidy Significant in Cancer?
What is the Role of Research Funding in Cancer Policies?
What Are the Treatment Options for PR Positive Cancer?
What Are the Implications of Circadian Disruption in Cancer Risk?
Are There Recent Advances Involving Taxol?
What is Nitrogen Mustard?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe